文献速递疼痛医学神经外科与老年麻醉

RNA结合蛋白SYNCRIP通过稳定CCR2表达参与神经病理性疼痛

RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones.
PubMed 文献 · Br J Anaesth · 2024-09-07

该研究在小鼠慢性坐骨神经压迫模型中发现,背根神经节SYNCRIP在CCI后3-14天表达上调,其通过结合Ccr2 mRNA 3-UTR稳定CCR2表达,参与神经病理性疼痛的发生与维持;敲低Syncrip可减轻痛敏,过表达则诱导痛敏。

要点

  • CCI后DRG神经元中SYNCRIP表达时间依赖性上调,与CCR2共定位。
  • DRG内敲低Syncrip可减轻CCI诱导的CCR2上调和痛觉过敏。
  • DRG内过表达Syncrip可升高CCR2并诱导 naive 小鼠痛敏和持续痛。

核心结论

  • SYNCRIP可能通过稳定损伤DRG中CCR2的表达参与神经病理性疼痛的诱导和维持,并可能成为治疗靶点。

研究设计与样本

  • 小鼠单侧坐骨神经慢性压迫损伤(CCI)模型,评估DRG中SYNCRIP表达与分布。
  • 向同侧L3和L4 DRG显微注射Syncrip小干扰RNA或AAV5-Syncrip,观察对CCR2表达和痛阈的影响。

主要发现

  • SYNCRIP主要表达于DRG神经元,并与CCR2共存。
  • CCI后3-14天,损伤DRG中Syncrip mRNA和SYNCRIP蛋白水平时间依赖性升高。
  • DRG显微注射Syncrip小干扰RNA减弱CCI诱导的DRG CCR2上调和痛觉过敏的发生与维持。
  • DRG显微注射AAV5-Syncrip升高注射侧DRG CCR2表达,增强对机械、热和冷刺激的反应,并在naive小鼠诱导持续痛。
  • 机制上,SYNCRIP结合Ccr2 mRNA的3-UTR并稳定其在DRG神经元中的表达。

临床怎么用

  • SYNCRIP–CCR2通路可能作为神经病理性疼痛的潜在干预靶点,但尚需临床转化验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nerve injury-induced changes in gene expression in the dorsal root ganglion (DRG) contribute to the genesis of neuropathic pain. SYNCRIP, an RNA-binding protein, is critical for the stabilisation of gene expression. Whether SYNCRIP participates in nerve injury-induced alterations in DRG gene expression and nociceptive hypersensitivity is unknown. METHODS: The expression and distribution of SYNCRIP in mouse DRG after chronic constriction injury (CCI) of the unilateral sciatic nerve were assessed. Effect of microinjection of Syncrip small interfering RNA into the ipsilateral L3 and L4 DRGs on the CCI-induced upregulation of chemokine (C-C motif) receptor 2 (CCR2) and nociceptive hypersensitivity were examined. Additionally, effects of microinjection of adeno-associated virus 5 expressing full length Syncrip mRNA (AAV5-Syncrip) on basal DRG CCR2 expression and nociceptive thresholds were observed. RESULTS: SYNCRIP is expressed predominantly in DRG neurones, where it co-exists with CCR2. Levels of Syncrip mRNA and SYNCRIP protein in injured DRG increased time-dependently on days 3-14 after CCI. Blocking this increase through microinjection of Syncrip small interfering RNA into injured DRG attenuated CCI-induced upregulation of DRG CCR2 and development and maintenance of nociceptive hypersensitivities. Mimicking this increase through DRG microinjection of AAV5-Syncrip elevated CCR2 expression in microinjected DRGs, enhanced the responses to mechanical, heat, and cold stimuli, and induced ongoing pain in naive mice. Mechanistically, SYNCRIP bound to 3-UTR of Ccr2 mRNA and stabilised its expression in DRG neurones. CONCLUSIONS: SYNCRIP contributes to the induction and maintenance of neuropathic pain likely through stabilising expression of CCR2 in injured DRG. SYNCRIP may be a potential target for treating this disorder.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Wang B, Feng X, et al. RNA-binding protein SYNCRIP contributes to neuropathic pain through stabilising CCR2 expression in primary sensory neurones. Br J Anaesth. 2024. PMID: 39244479. doi:10.1016/j.bja.2024.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。